Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Endogenous peptide neurotransmitter, involved i...
Efflux pump inhibitor
NLRP3 and caspase-1 inhibitor.
Fluoroquinolone; topoisomerase IV, topoisomeras...
Endogenous peptide, involved in vascular contra...
Fluoroquinolone; topoisomerase IV and bacterial...
Thiazolidinone macrolide found in the Red Sea s...
MEK1 inhibitor.
Potential voltage-gated Na+ channel blocker.
NSAID; COX-1/2 and lactate dehydrogenase inhibi...
CDK4/6 inhibitor.
STING antagonist
Alkaloid found in Galanthus, Narcissus, Leucoju...
Synthetic progestogen; contraceptive.
Hedgehog and Smo agonist.
Caspase 9 substrate.
Polypeptide; peptidoglycan inhibitor.
LRRK2 inhibitor.
Akt inhibitor.
Endogenous opioid peptide derived from the β-c...